Pfizer company headlines, earnings, strategy, leadership, and market-moving business updates.
Market data may be delayed. For informational purposes only. Not investment advice.
A recent market-oriented article highlights how dividend payments from large healthcare companies can be translated into a simple annual cash-flow estimate for shareholders, using Pfizer and Johnson & Johnson as examples.
THE APEX TIMES
THE APEX TIMES
Pfizer (PFE) closed at $25.22, down 2.72% from the prior session, in a move the latest market commentary linked to changing conditions for investors.
THE APEX TIMES
The drugmaker said it has appointed an interim head of finance following the exit of its chief financial officer, while confirming it expects to meet its full-year guidance.
THE APEX TIMES
Dave Denton will leave Pfizer in August, according to a market report, as the drugmaker works through a post-COVID operating reset.
THE APEX TIMES
Cecile Guegan is set to become interim CFO on Aug. 16 as the drugmaker begins a search for Denton’s successor.
THE APEX TIMES
The pharmaceutical company said Chief Financial Officer Dave Denton will leave the firm in August and that Senior Vice President Cecile Guegan will serve as interim CFO starting when Denton exits.
THE APEX TIMES
A Yahoo Finance segment spotlighted Pfizer (PFE) alongside Accenture (ACN) and Kroger (KR), framing the names as part of the day’s moving “Trending Tickers” without detailing the specific fundamentals in the materials available.
THE APEX TIMES
The pharmaceutical company said CFO Dave Denton, who joined Pfizer in 2022 from Lowe’s, will depart for an unspecified “professional opportunity” in consumer goods.
THE APEX TIMES
Pfizer said its chief financial officer, Dave Denton, will step down, prompting a search for his replacement. In the same day’s biotech headlines, Denali Therapeutics’ regulatory strategy and a venture-backed Duchenne gene therapy featuring a GSK-linked deal highlighted shifting momentum across the sector.
